Explorer
Japan: Remdesivir approved for Coronavirus treatment
The development of Remdesivir had started in 2009 and was used for Ebola patients during the 2000s. The medication was recently given a fast-track approval in Japan for the treatment of Coronavirus patients. Gilead Sciences company that produces Remdesivir, had applied for the approval of this drug only three days ago.
The US is also planning to begin treating seriously ill COVID-19 patients with Remdesivir.
The US is also planning to begin treating seriously ill COVID-19 patients with Remdesivir.
Maharashtra
BMC Elections 2026: Mumbai BMC Mayor Post Still Unclear Weeks After Election Results
Breaking News: Security Forces Engage Militants in Singhpur Forest Amid Search Operation
Breaking News: BJP Slams Congress Over Controversial Statement on Women
Breaking News: Mauni Amavasya Mela, Swami Avimukteshwaranand Alleges Police Brutality on Saints
Breaking News: Ahilyabai Holkar Statue Row, Congress Questions Varanasi Redevelopment
View More


























